UTHR:NASDAQ
United Therapeutics Corp
$536.10
arrow_downward
-0.06%(-0.30) 1D
Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 12 analysts giving stock ratings to UTHR in the past 3 months
Buy
Buy
9
Hold
2
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for UTHR in the last 3 months.
Highest
Current $536.10
$728.00 (+35.80%)
Average
$638.75 (+19.15%)
Lowest
$321.00 (-40.12%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Roanna Ruiz Leerink Partners | Buy | Reiterated | $685.00 | +27.8% | 10/01/2026 |
Roger Song Jefferies | Buy | Maintained | $704.00 | +31.3% | 10/01/2026 |
Julian Harrison BTIG | Buy | Upgraded | $728.00 | +35.8% | 10/01/2026 |
Olivia Brayer Cantor Fitzgerald | Buy | Initiated | $700.00 | +30.6% | 09/30/2026 |
Lisa Walter RBC Capital | Buy | Reiterated | $677.00 | +26.3% | 09/30/2026 |
Andrea Newkirk Goldman Sachs | Sell | Initiated | $321.00 | -40.1% | 09/24/2026 |
Benjamin Burnett Wells Fargo | Buy | Maintained | $700.00 | +30.6% | 09/02/2026 |
Joseph Thome TD Cowen | Buy | Maintained | $675.00 | +25.9% | 09/02/2026 |
Andrew Fein H.C. Wainwright | Buy | Maintained | $660.00 | +23.1% | 08/06/2026 |
Terence Flynn Morgan Stanley | Hold | Reiterated | $515.00 | -3.9% | 08/06/2026 |
Jessica Fye J.P. Morgan | Buy | Maintained | $687.00 | +28.1% | 07/23/2026 |
Jason Gerberry Bank of America Securities | Hold | Reiterated | $613.00 | +14.3% | 07/10/2026 |
Unknown Analyst J.P. Morgan | Buy | Maintained | $685.00 | +27.8% | 05/20/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $700.00 | +30.6% | 04/09/2026 |
Tiago Fauth Raymond James | Buy | Initiated | $700.00 | +30.6% | 04/09/2026 |
Andreas Argyrides Oppenheimer | Buy | Maintained | $650.00 | +21.2% | 03/12/2026 |
Ashwani Verma UBS | Buy | Reiterated | $705.00 | +31.5% | 03/05/2026 |
Jasper Hellweg Argus Research | Buy | Reiterated | $560.00 | +4.5% | 03/03/2026 |